Quickly Spot Consensus Among the World’s Best Equity Analysts
| Name | Upside % |
Analysts bullish % |
|
|---|---|---|---|
|
49%
upside
6 price targets
|
0
%
|
|
|
|
49%
upside
7 price targets
|
0
%
|
|
|
|
49%
upside
6 price targets
|
0
%
|
|
|
104
Viridian Therapeutics
VRDN
$2.68B
|
48%
upside
5 price targets
|
0
%
|
|
|
48%
upside
8 price targets
|
0
%
|
|
|
|
48%
upside
3 price targets
|
0
%
|
|
|
|
47%
upside
3 price targets
|
0
%
|
|
|
|
46%
upside
7 price targets
|
0
%
|
|
|
|
46%
upside
11 price targets
|
0
%
|
|
|
|
46%
upside
10 price targets
|
0
%
|
|
|
|
ANDG
111
Andersen Group
ANDG
$2.42B
|
45%
upside
6 price targets
|
0
%
|
|
|
45%
upside
3 price targets
|
0
%
|
|
|
|
45%
upside
8 price targets
|
0
%
|
|
|
|
44%
upside
12 price targets
|
0
%
|
|
|
|
44%
upside
9 price targets
|
0
%
|
|
|
|
44%
upside
12 price targets
|
0
%
|
|
|
|
43%
upside
3 price targets
|
0
%
|
|
|
|
42%
upside
3 price targets
|
0
%
|
|
|
|
42%
upside
8 price targets
|
0
%
|
|
|
|
42%
upside
5 price targets
|
0
%
|
|
|
|
42%
upside
3 price targets
|
0
%
|
|
|
|
41%
upside
4 price targets
|
0
%
|
|
|
|
41%
upside
11 price targets
|
0
%
|
|
|
|
41%
upside
3 price targets
|
0
%
|
|
|
|
40%
upside
6 price targets
|
0
%
|
|